Pharma - HealthQuill

Eli Lilly’s Alzheimer’s experimental drug, donanedab, slowed down cognitive and functional decline in people with early symptoms of the disease, according to a company statement.

Argenx’s Vyvgart faces setback in autoimmune treatment trial

HQ Team November 28, 2023: Argenx SE, a Belgian biopharmaceutical announced that its experimental drug Vyvgart Hytrulo failed in trials in treating immune.

by HealthQuill
November 28, 2023
0 Comments

Climate Health Pharma

Environment, lifestyle behind epidemic of autoimmune diseases

HQ Team November 28, 2023: An escalating global crisis is unfolding as an increasing number of individuals grapple with autoimmune diseases, conditions wherein.

by HealthQuill
November 28, 2023
0 Comments

German biotechnology company, BioNTech SE announced a $ 90 million program in partnership with the Coalition for Epidemic Preparedness Innovations (CEPI) to develop a vaccine for mpox.

Health Medical Pharma

WHO confirms 1st case of sexual spread of Mpox in Congo

HQ Team November 25, 2023: The first Mpox patient to contact the disease through sexual contact has been confirmed by the WHO in.

by HealthQuill
November 25, 2023
0 Comments

A bacterium, staphylococcus aureus, single-handedly imbalances the equilibrium of micro-organisms, that keep the skin healthy, and cause itching, according to researchers at Harvard Medical School.

Drugs Health Pharma

Bacterium S. aureus behind happiness of having to scratch for every itch

HQ Team November 24, 2023: A bacterium, staphylococcus aureus, single-handedly imbalances the equilibrium of micro-organisms, that keep the skin healthy, and cause itching,.

by HealthQuill
November 24, 2023
0 Comments

One in five children and young people in England aged between eight and 25 had a probable mental disorder in 2023, a report by the National Health Service, a publicly-funded healthcare system, found.

Drugs Health Pharma

1 in 5 kids, young people in England probably had a mental disorder in 2023

HQ Team November 24, 2023: One in five children and young people in England aged between eight and 25 had a probable mental.

by HealthQuill
November 24, 2023
0 Comments

The World Health Organisation is monitoring an increase in children’s illness caused by pathogens, including acute respiratory syndrome coronavirus 2, in northern China.

Climate Health Pharma

WHO keeping an eye on a surge of respiratory illness in northern China

The World Health Organization is monitoring an increase in children’s illness caused by pathogens, including acute respiratory syndrome coronavirus 2, in northern China.

by HealthQuill
November 24, 2023
0 Comments

— at a time when President Emmanuel Macron is taking steps to stem the country’s industrial decline.

Drugs Health Pharma

Novo Nordisk invests $2.3b in France for diabetes, obesity drugs

HQ Team November 23, 2023: Novo Nordisk will invest $2.3 billion to expand production of its weight-loss and diabetes drug in Chartes, France..

by HealthQuill
November 23, 2023
0 Comments

Tumour molecules can rob the human body’s immune cells to deprive them of their energy to fuel the invaders’ own needs, researchers find.

Drugs Health Pharma

Vampiric tumour cells can hijack human body’s immune cell energy

HQ Team November 22, 2023: Tumour molecules can rob the human body’s immune cells to deprive them of their energy to fuel the.

by HealthQuill
November 22, 2023
0 Comments

Health emergencies, prevention, preparedness, and response, will top the agenda at the second Health Working Group meeting of G20 member nations during the two-day meeting starting in India today.

Drugs Medical Pharma

Zevra Therapeutics completes acquisition of Acer in a $91m deal

HQ Team November 21, 2023: Zevra Therapeutics, Inc. has finalized its acquisition of Acer Therapeutics Inc in a $91m deal. This strategic acquisition.